Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.
N-Methanocarbathymidine [(N)-MCT] is a conformationally locked nucleoside analog that is active against some herpesviruses and orthopoxviruses in vitro. The antiviral activity of this molecule is dependent on the type I thymidine kinase (TK) in herpes simplex virus and also appears to be dependent on the type II TK expressed by cowpox and vaccinia viruses, suggesting that it is a substrate for both of these divergent forms of the enzyme. The drug is also a good inhibitor of viral DNA synthesis in both viruses and is consistent with inhibition of the viral DNA polymerase once it is activated by the viral TK homologs. This mechanism of action explains the rather unusual spectrum of activity, which is limited to orthopoxviruses, alphaherpesviruses, and Epstein-Barr virus, since these viruses express molecules with TK activity that can phosphorylate and thus activate the drug. The compound is also effective in vivo and reduces the mortality of mice infected with orthopoxviruses, as well as those infected with herpes simplex virus type 1 when treatment is initiated 24 h after infection. These results indicate that (N)-MCT is active in vitro and in vivo, and its mechanism of action suggests that the molecule may be an effective therapeutic for orthopoxvirus and herpesvirus infections, thus warranting further development.
Prichard
Mark N
MN
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL 35233, USA. mprichard@peds.uab.edu
Keith
Kathy A
KA
Quenelle
Debra C
DC
Kern
Earl R
ER
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002478:Cells, Cultured; D004279:DNA, Viral / Q000096:biosynthesis; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D010766:Phosphorylation; D011213:Poxviridae Infections / Q000188:drug therapy*; D013936:Thymidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D013937:Thymidine Kinase / Q000378:metabolism
D000998:Antiviral Agents; D004279:DNA, Viral; D013937:Thymidine Kinase; C469995:(north)-methanocarbathymidine; D013936:Thymidine